Momenta Pharma drops sharply after Bloomberg reports appeals court loss The shares are down nearly 5% on the heels of the Bloomberg report. Next support is at $13, and then at $12.63.
News For MNTA From The Last 14 Days
Check below for free stories on MNTA the last two weeks.